{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:46:31Z","timestamp":1782589591020,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003061","name":"Erasmus Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003061","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.phro.2026.101004","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:41:13Z","timestamp":1779900073000},"page":"101004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Potential normal tissue sparing in vulvar cancer using intensity modulated proton therapy versus volumetric modulated arc therapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Anna C.","family":"Prins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s G.","family":"Zolnay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A.","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mischa S.","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Ng Wei Siang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2026.101004_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.phro.2026.101004_b0010","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/ijc.30821","article-title":"Prevalence and type distribution of human papillomavirus in squamous cell carcinoma and intraepithelial neoplasia of the vulva","volume":"141","author":"Faber","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.phro.2026.101004_b0015","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/ijgc-2023-004486","article-title":"European Society of Gynaecological Oncology guidelines for the management of patients with vulvar cancer - update 2023","volume":"33","author":"Oonk","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.phro.2026.101004_b0020","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.prro.2024.08.006","article-title":"Use of radiation therapy in the management of vulvar cancers - identification and management of acute and late toxicities","volume":"15","author":"DeCesaris","year":"2025","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2024.09.003","article-title":"Adjuvant radiotherapy of the vulva in primary vulvar cancer: a systematic review","volume":"190","author":"Proppe","year":"2024","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.hoc.2019.08.006","article-title":"Proton therapy","volume":"33","author":"LaRiviere","year":"2019","journal-title":"Hematol Oncol Clin N Am"},{"key":"10.1016\/j.phro.2026.101004_b0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.radonc.2016.06.016","article-title":"Which cervical and endometrial cancer patients will benefit most from intensity\u2013modulated proton therapy?","volume":"120","author":"van de Sande","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0040","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2023.01.004","article-title":"Treatment tolerability and toxicity of postoperative proton beam therapy for gynecologic malignancies: results of the prospective phase 2 APROVE trial","volume":"116","author":"Arians","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13014-015-0402-z","article-title":"Which radiation technique is most beneficial for patients with locally advanced cervical cancer? An intraindividual comparison of IMPT, IMRT, tomotherapy and VMAT","volume":"10","author":"Marnitz","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0050","doi-asserted-by":"crossref","first-page":"e477","DOI":"10.1016\/j.ijrobp.2011.07.012","article-title":"Dosimetric comparison of combined IMRT and proton therapy versus IMRT alone for pelvic and para\u2013aortic radiotherapy in gynecologic malignancies","volume":"82","author":"Milby","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0055","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2019.04.015","article-title":"Quantification of acute skin toxicities in patients with breast cancer undergoing adjuvant proton versus photon radiation therapy","volume":"104","author":"DeCesaris","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tipsro.2021.05.001","article-title":"Evaluation of skin reactions during proton beam radiotherapy\u2013patient\u2013reported versus clinician\u2013reported","volume":"19","author":"M\u00f6llerberg","year":"2021","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0065","series-title":"ICRU report 78: prescribing, recording, and reporting proton beam therapy","author":"International Commission on Radiation Units and Measurements","year":"2007"},{"key":"10.1016\/j.phro.2026.101004_b0070","first-page":"1463","article-title":"Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities: the importance of the \u03b1\/\u03b2 ratio","volume":"58","author":"Paganetti","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0075","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0080","unstructured":"MIM Software Inc. Contour Prot\u00e9g\u00e9 AI+\u2122. Version 2024 [software]. Cleveland (OH): MIM Software Inc.; 2024. Available from: https:\/\/www.mimsoftware.com\/radiation-oncology\/contour-protegeai-plus; accessed 6 May 2026."},{"key":"10.1016\/j.phro.2026.101004_b0085","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2006.03.018","article-title":"Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and IMRT","volume":"66","author":"Mell","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s13014-020-01606-3","article-title":"Pelvic bone marrow\u2013sparing IMRT reduces hematologic toxicity in cervical cancer patients receiving chemoradiotherapy: a randomized trial","volume":"15","author":"Huang","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0095","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1118\/1.3556559","article-title":"Minimax optimization for handling range and setup uncertainties in proton therapy","volume":"38","author":"Fredriksson","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2026.101004_b0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1118\/1.3021139","article-title":"Reducing the sensitivity of IMPT plans to setup errors and range uncertainties via probabilistic treatment planning","volume":"36","author":"Unkelbach","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2026.101004_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1138433","article-title":"Impact of bone marrow sparing on organ\u2013at\u2013risk dose for cervical cancer: a Pareto front analysis","volume":"13","author":"Kuipers","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.meddos.2023.10.009","article-title":"Treatment planning of scanned proton beams in RayStation","volume":"49","author":"Janson","year":"2024","journal-title":"Med Dosim"},{"key":"10.1016\/j.phro.2026.101004_b0115","first-page":"97","article-title":"ICRU\u2013report 83","volume":"188","author":"Der","year":"2012","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2026.101004_b0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2019.08.005","article-title":"Practical robustness evaluation in radiotherapy\u2013an alternative to PTV\u2013based plan evaluation","volume":"141","author":"Korevaar","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijrobp.2012.09.023","article-title":"RTOG 0529: dose\u2013painted IMRT with fluorouracil and mitomycin C for anal canal carcinoma","volume":"86","author":"Kachnic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0130","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.ijrobp.2012.02.044","article-title":"Postoperative IMRT to the pelvis for endometrial carcinoma: RTOG 0418","volume":"84","author":"Jhingran","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0135","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1200\/JCO.23.02235","article-title":"Cisplatin, gemcitabine, and IMRT for locally advanced vulvar SCC: NRG oncology\/GOG279","volume":"42","author":"Horowitz","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2024.07.2314","article-title":"Pelvic bone marrow\u2013sparing IMRT reduces bone mineral density loss in cervical cancer","volume":"121","author":"Huang","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0145","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.3390\/cancers16101842","article-title":"Hematologic toxicity and bone marrow sparing strategies in chemoradiation for locally advanced cervical cancer: a systematic review","volume":"16","author":"Konnerth","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phro.2026.101004_b0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13014-018-0961-x","article-title":"Fitting NTCP models to bladder dose and acute urinary symptoms during post\u2013prostatectomy radiotherapy","volume":"13","author":"Mavroidis","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0155","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3390\/cancers13061390","article-title":"Biophysical analysis of toxicity in gastric MZL: Impact of dose and PTV","volume":"13","author":"Reinartz","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phro.2026.101004_b0160","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.ijrobp.2011.12.012","article-title":"NTCP analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing IMRT with concurrent cisplatin","volume":"83","author":"Simpson","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0165","first-page":"810","article-title":"NTCP models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial [conference abstract]","volume":"182","author":"Corbeau","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0360-3016(91)90172-Z","article-title":"Fitting of normal tissue tolerance data to an analytic function","volume":"21","author":"Burman","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0175","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1080\/0284186X.2018.1468082","article-title":"Dose\u2013response relationships of the sigmoid colon for urgency syndrome after gynecological radiotherapy","volume":"57","author":"Alevronta","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0180","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.ijrobp.2013.09.017","article-title":"Impact of chemotherapy on NTCP models of acute hematologic toxicity in pelvic IMRT","volume":"87","author":"Bazan","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0185","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fonc.2020.00344","article-title":"NTCP models for severe radiation\u2013induced dermatitis after IMRT or proton therapy","volume":"10","author":"Palma","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmp.2019.02.005","article-title":"A new formalism of dose\u2013surface histograms for robust modeling of skin toxicity","volume":"59","author":"Palma","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2026.101004_b0195","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/archinte.1916.00080130010002","article-title":"Clinical calorimetry: a formula to estimate body surface area","volume":"17","author":"Du Bois","year":"1916","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.phro.2026.101004_b0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmp.2019.02.015","article-title":"Skin DVHs predict cutaneous toxicity in head and neck cancer patients treated with tomotherapy","volume":"59","author":"Mori","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2026.101004_b0205","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2307\/1412159","article-title":"The proof and measurement of association between two things","volume":"15","author":"Spearman","year":"1904","journal-title":"Am J Psychol"},{"key":"10.1016\/j.phro.2026.101004_b0210","doi-asserted-by":"crossref","first-page":"987","DOI":"10.2214\/AJR.07.3634","article-title":"Pelvic bone complications after radiotherapy for cervical cancer: MRI evaluation","volume":"191","author":"Kwon","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.phro.2026.101004_b0215","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ijrobp.2007.08.005","article-title":"Pelvic insufficiency fractures after radiotherapy for cervical cancer","volume":"70","author":"Oh","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2026.101004_b0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/jrr\/rrae008","article-title":"NTCP for hematologic and GI toxicity in postoperative whole\u2013pelvic IMPT","volume":"65","author":"Yoshimura","year":"2024","journal-title":"J Radiat Res"},{"key":"10.1016\/j.phro.2026.101004_b0225","article-title":"Incidence and predictors of toxicity in vulvar squamous cell carcinoma treated with radiation therapy","volume":"44","author":"McCall","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.phro.2026.101004_b0230","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1748-717X-9-202","article-title":"Single\u2013field integrated boost planning for spot\u2013scanning proton therapy","volume":"9","author":"Zhu","year":"2014","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0235","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s13014-018-1124-9","article-title":"Comparing SIB versus sequential boost in anal cancer","volume":"13","author":"Franco","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109856","article-title":"Assessment of residual geometrical errors of clinical target volumes and impact on dose accumulation","volume":"188","author":"Ng Wei Siang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2026.101004_b0245","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for proton radiotherapy aiming at reduction of side effects: the model\u2013based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631626001041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:29:52Z","timestamp":1782588592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631626001041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":49,"alternative-id":["S2405631626001041"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2026.101004","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential normal tissue sparing in vulvar cancer using intensity modulated proton therapy versus volumetric modulated arc therapy","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2026.101004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101004"}}